Summit and Akeso's ivonescimab attracted headlines earlier this year when it was shown to be more effective than anti-PD-1 ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Real-World Adherence to Repeat Testing for Stool-Based Non-Invasive Colorectal Cancer Screening Tests Among Individuals ... PhD, et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With ...

In our country, 4 out of 10 adults are overweight, and slightly more than 1 in 10 live with a condition of obesity, a chronic ...

Eli Lilly and Company (NYSE: LLY) announced today detailed results from the Phase 3 SURMOUNT-1 three-year study (176-week treatment period), the longest completed study to date of tirzepatide ... at ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

The biotech believes that azelaprag can amplify the weight loss achieved with tirzepatide and other obesity ... in its 'macrocycle' class of drugs for cancer and other serious diseases.

Eli Lilly has been making quite a bit of noise thanks to its work in diabetes and obesity. Investors turned on the company, ...